{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The recessive nature of the PINK1 mutations suggests that loss of function is associated with disease, further implying that the PINK1 kinase activity is important in protecting nigral neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a loss of function due to impaired kinase activity leading to neuronal damage."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We examined whether mutations in PINK1 affect kinase activity by using the autophosphorylation assay previously shown to be useful for this protein in vitro.",
          "judgment": "Yes",
          "reasoning": "The autophosphorylation assay is a standard method to assess kinase activity, directly relevant to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3a: Basic Controls and Replicates",
          "extracted_paper_info": "Autophosphorylation was limited to the intact GST-PINK1 protein, not degradation products. Differences in autophosphorylation activity between different recombinant proteins (n = 3) were analyzed by using ANOVA.",
          "judgment": "Yes",
          "reasoning": "The study included wild-type and mutant controls, and experiments were performed in triplicate, meeting the criteria for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3c: Variant Controls",
          "extracted_paper_info": "We tested two recessive mutations and found that although G309D had somewhat decreased activity (60.5% of wild type; P = 0.01).",
          "judgment": "No",
          "reasoning": "No known pathogenic or benign variant controls were explicitly mentioned in the context of the assay.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G309D variant showed decreased kinase activity, supporting its pathogenicity. However, due to the lack of variant controls, the evidence strength is limited to supporting."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The recessive nature of the PINK1 mutations suggests that loss of function is associated with disease, further implying that the PINK1 kinase activity is important in protecting nigral neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a loss of function due to impaired kinase activity leading to neuronal damage."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We examined whether mutations in PINK1 affect kinase activity by using the autophosphorylation assay previously shown to be useful for this protein in vitro.",
          "judgment": "Yes",
          "reasoning": "The autophosphorylation assay is a standard method to assess kinase activity, directly relevant to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3a: Basic Controls and Replicates",
          "extracted_paper_info": "Autophosphorylation was limited to the intact GST-PINK1 protein, not degradation products. Differences in autophosphorylation activity between different recombinant proteins (n = 3) were analyzed by using ANOVA.",
          "judgment": "Yes",
          "reasoning": "The study included wild-type and mutant controls, and experiments were performed in triplicate, meeting the criteria for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3c: Variant Controls",
          "extracted_paper_info": "We tested two recessive mutations and found that L347P had drastically decreased activity (<10% of wild type).",
          "judgment": "No",
          "reasoning": "No known pathogenic or benign variant controls were explicitly mentioned in the context of the assay.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The L347P variant showed a significant decrease in kinase activity and protein stability, supporting its pathogenicity. However, due to the lack of variant controls, the evidence strength is limited to supporting."
    }
  ]
}
